Pharmacogenetics of Tacrolimus and Cyclosporine A in Patients after Kidney Transplantation

被引：0
|
作者：
Bandur, S. [1 ]
Hribova, P. [1 ]
Novotna, E. [1 ]
Brabcova, I. [1 ]
Viklicky, O. [1 ,2 ]
机构：
[1] IKEM, Transplant Lab, Prague, Czech Republic
[2] IKEM, Transplantctr, Nephrol Clin, Prague, Czech Republic
来源：
KIDNEY & BLOOD PRESSURE RESEARCH | 2008年 / 31卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
29
引用
收藏
页码：388 / 388
页数：1
相关论文
共 50 条
  • [1] Tacrolimus pharmacogenetics and acute kidney injury after lung transplantation
    Miano, Todd
    Flesch, Judd
    Diamond, Joshua
    Christie, Jason
    Feng, Rui
    Forker, Caitlin
    Brown, Melanie
    Oyster, Michelle
    Cantu, Edward
    Porteus, Mary
    Kalman, Laurel
    Rushefski, Melanie
    Localio, Russel
    Shashaty, Michael
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 349 - 350
  • [2] Successful conversion from tacrolimus to cyclosporine after kidney transplantation
    Yashima, J
    Koyama, I
    Ishida, H
    Sawada, T
    Tojimbara, T
    Nakajima, I
    Fuchinoue, S
    Agishi, T
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1693 - 1693
  • [3] Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
    Yu, Meng
    Liu, Mouze
    Zhang, Wei
    Ming, Yingzi
    [J]. CURRENT DRUG METABOLISM, 2018, 19 (06) : 513 - 522
  • [4] Survival In Kidney Transplantation In Patients Who Used Cyclosporine Or Tacrolimus
    Gomes, Rosangela Maria
    Guerra Junior, Augusto Afonso
    Pires Lemos, Livia Lovato
    Barbosa, Wallace Breno
    Acurcio, Francisco Assis
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 538 - 538
  • [5] The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation
    MacPhee, IAM
    Fredericks, S
    Tai, T
    Syrris, P
    Carter, ND
    Johnston, A
    Goldberg, L
    Holt, DW
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) : 914 - 919
  • [6] Cyclosporine versus tacrolimus in kidney transplantation: Are there differences in nephrotoxicity?
    Martins, L
    Ventura, A
    Branco, A
    Carvalho, MJ
    Henriques, AC
    Dias, L
    Sarmento, AM
    Amil, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (04) : 877 - 879
  • [7] Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity
    Hariharan, S
    Munda, R
    Cavallo, T
    Demmy, AM
    Schroeder, TJ
    Alexander, JW
    First, MR
    [J]. TRANSPLANTATION, 1996, 61 (08) : 1161 - 1165
  • [8] Is there a different impact of cyclosporine versus tacrolimus on delayed graft function after kidney transplantation?
    Hanack, U
    Lorf, T
    Braun, F
    Grupp, C
    Sattler, B
    Binder, L
    Müller, GA
    Ringe, B
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2293 - 2293
  • [9] Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation
    MacDonald, AS
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 201S - 208S
  • [10] Comparison of tacrolimus with a cyclosporine microemulsion for immunosuppressive therapy in kidney transplantation
    Ekmekcioglu, Ozan
    Turkan, Sadi
    Yildiz, Sener
    Gunes, Zeki Ender
    [J]. TURKISH JOURNAL OF UROLOGY, 2013, 39 (01): : 16 - 21
12345